About Cornerstone

Cornerstone is committed to helping the medicare eligible make the right healthcare choices. The ever-changing, fast-paced world we live in, high tech progress and advances, not to mention the changes in law and policies governing healthcare, makes it almost an impossibility for anyone to make a knowledgeable decision when it comes to healthcare.

We are not a corporation which means we not only hear, but we listen to your specific needs and wants that you desire in a healthcare plan.

Community Involvement

We believe in giving back to our community, not only financially, but with our most valuable resource: our time.

Micah House

Helping feed those less fortunate by providing a meal and distributing clothes when needed.

Heartbeat of Northwest Ohio

Mentoring young men on what it is to be a father.The duties and responsibilities of parenthood.

The Pontifex

A community outreach center that incorporates a food kitchen, a school uniform assistance program, food pantry and other help programs.

Liberty Center

The areas homeless shelter which concentrates on families who have fallen on hard times.
Giving counseling and helping them contact agencies that will assist during this time

“Here at Cornerstone we are committed to making theworld a better place by living and walking out theAmerican motto ‘In God We Trust’,” says Dave Obregon.

Having the right kinds of insurance allows you to live the good life without worry. Call Cornerstone today to discuss your insurance needs. Call (888) 355-1599, or Mobile: (419) 307-5743

Search for:

Subscribe to Blog via Email

Enter your email address to subscribe to the Cornerstone blog and receive notifications of new posts by email.

Led by Lawson Health Research Institute, London Health Sciences Centre (LHSC), University Health Network (UHN) and General Dynamics Land Systems-Canada (GDLS-Canada), researchers have designed a non-invasive ventilation mask that could significantly reduce aerosolization—the production of airborne respiratory droplets that may contain viruses or bacteria—when treating patients with COVID-19. The new device aims to reduce infection […]

The first study to report use of the rheumatoid arthritis drug anakinra to treat COVID-19 patients found that high-dose anakinra was safe and was associated with respiratory improvements and reduced signs of cytokine storm in 72% (21/29) of patients, according to results from patients studied for 21 days (enrolled from 17 to 27 March 2020) […]